Needham Thomas E. Jr. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Aug 3, 2017
Insider Transaction Report
Form 4
Needham Thomas E. Jr.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2017-08-01+450,000→ 450,000 totalExercise: $1.28Exp: 2027-07-31→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]This option vests as to 1/6th of the total number of shares granted on 1/24/18 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 7/24/20.